News | Stethoscopes | November 15, 2016

Pilot Study Results Support Efficacy of eMurmur Computer-Aided Auscultation Platform

Software platform demonstrates high sensitivity and specificity in differentiating innocent versus pathologic pediatric heart murmurs

CSD Labs, eMurmur computer-aided auscultation software platform, pilot study, heart murmurs in children

November 15, 2016 — Computational Signal Detection (CSD) Laboratories LLC announced the publication of data in support of the clinical utility of its eMurmur computer-aided auscultation (CAA) platform for early and ongoing heart-health screening of children.

According to the company, up to 90 percent of children will have a heart murmur at some point during their infancy or childhood. However, the majority of these heart murmurs detected in children will be clinically insignificant.

In this pilot study of 106 children at Children’s Hospital of Eastern Ontario, eMurmur differentiated pathologic from innocent heart murmurs with high sensitivity (87 percent) and specificity (100 percent), a positive predictive value of 100 percent, a negative predictive value of 90 percent, and high accuracy (94 percent) when compared with echocardiography as the gold standard for diagnosing murmurs.

CSD Labs has also clinically validated eMurmur as a tool for early and ongoing heart-health screening of teens, adults and elderly persons.

eMurmur is a software platform for the objective detection of heart murmurs that analyzes and classifies heart sounds acquired via an electronic stethoscope. The platform is comprised of an app that runs on a mobile device and is powered by SADIE, a Machine Intelligence Signal Analysis/Diagnosis Engine. Via Bluetooth or audio cable, the app pairs with any commercially available electronic stethoscope or other appropriate recording device, and receives and sends the acquired heart sounds to the HIPAA-compliant server for analysis. After a few seconds, the results are displayed to the healthcare professional on his/her mobile device where he/she can review, compare, consult or add his/her own findings in an efficient and standardized way.

CSD LABS CEO and Founder Andreas Schriefl, Ph.D., said eMurmur’s web portal offers medical professionals the capacity to retrieve a PDF report containing all results, and enables integration into electronic patient files and hospital information systems. Other benefits include e-consultation via the web portal (i.e., remote case reviewing by medical experts); and heart sound-monitoring by comparing current with previous auscultation data, including recordings and all findings.

For more information: www.csdlabs.com


Related Content

News | Cardiac Diagnostics

September 15, 2022 - Happitech has announced the launch of its FastStart Research app. The Amsterdam-based digital ...

Home September 15, 2022
Home
Feature | Cardiac Diagnostics | by Kelly Patrick

Like most healthcare markets, the diagnostic cardiology market has had a bumpy ride in recent years. The COVID-19 ...

Home August 23, 2022
Home
Feature | Cardiac Diagnostics | By Adam Saltman, MD, PhD

Before opining on the future of cardiac health, I think it’s important to define what “cardiac health” actually is. If ...

Home May 04, 2022
Home
News | Cardiac Diagnostics

January 31, 2022 — Scientists have developed an artificial intelligence (AI) system that can analyze eye scans taken ...

Home January 31, 2022
Home
News | Cardiac Diagnostics

November 10, 2021 — Abbott released new global market research from its Beyond Intervention initiative, the company’s ...

Home November 10, 2021
Home
Feature | Cardiac Diagnostics | By Dave Fornell, DAIC Editor

October 29, 2021 — A new guideline for the evaluation and diagnosis of chest pain was released this week that provides ...

Home October 29, 2021
Home
News | Cardiac Diagnostics

October 4, 2021 – Nanowear, a hospital-at-home and remote diagnostic platform that used proprietary wearable cloth ...

Home October 04, 2021
Home
News | Cardiac Diagnostics

September 28, 2021 — Biotricity Inc., a medical diagnostic and consumer healthcare technology company, has developed a ...

Home September 28, 2021
Home
News | Cardiac Diagnostics

July 29, 2021 — A recent clinical study from Overlake Medical Center utilizing the Bardy Diagnostics Carnation ...

Home July 29, 2021
Home
News | Cardiac Diagnostics

July 1, 2021 — The U.S. Food and Drug Administration (FDA) has cleared the Angel Medical Systems Inc. second-generation ...

Home July 01, 2021
Home
Subscribe Now